Jan Tavernier

7PUBLICATIONS
63CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 14, 2024
Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced Exhaustion.

Stijn De Munter, Juliane L Buhl, Laurenz De Cock

|Mar 24, 2023
Mechanism of receptor assembly via the pleiotropic adipokine Leptin.

Alexandra Tsirigotaki, Ann Dansercoer, Koen H G Verschueren

|Nov 13, 2021
Selective IL-1 activity on CD8<sup>+</sup> T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication.

Bram Van Den Eeckhout, Leander Huyghe, Sandra Van Lint

|Nov 09, 2021
Bcl-xL acts as an inhibitor of IP<sub>3</sub>R channels, thereby antagonizing Ca<sup>2+</sup>-driven apoptosis.

Nicolas Rosa, Hristina Ivanova, Larry E Wagner

|Aug 03, 2021
Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function.

Manon Duquenne, Cintia Folgueira, Cyril Bourouh

|Jul 28, 2020
Specific targeting of IL-1β activity to CD8<sup>+</sup> T cells allows for safe use as a vaccine adjuvant.

Bram Van Den Eeckhout, Lien Van Hoecke, Elianne Burg

Pageof 2